Suchergebnisse - "Tada, Takuya"

PubPharm (7)

1

Single-epitope T cell-based vaccine protects against SARS-CoV-2 infection in a preclinical animal model

enthalten in: JCI insight | 2023

von Tada, T. | Peng, J. | Dcosta, B. | +1

2

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies

enthalten in: EBioMedicine | 2022

von Tada, T. | Zhou, H. | Dcosta, B. | +6

3

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens

enthalten in: Microbiology spectrum | 2022

von Counoupas, C. | Pino, P. | Stella, A. | +18

4

Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies

enthalten in: Frontiers in immunology | 2022

von Tada, T. | Zhou, H. | Samanovic, M. | +5

UpdateOf: bioRxiv. 2021 Aug 06;:. - PMID 34312623

5

High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals

enthalten in: Cell reports | 2022

von Tada, T. | Zhou, H. | Dcosta, B. | +5

6

B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies

enthalten in: mBio | 2021

von Zhou, H. | Dcosta, B. | Samanovic, M. | +3

UpdateOf: bioRxiv. 2021 Mar 24;:. - PMID 33791698

7

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes

enthalten in: mBio | 2021

von Tada, T. | Dcosta, B. | Samanovic, M. | +7

UpdateOf: bioRxiv. 2021 Feb 07;:. - PMID 33564768

1
[1]